Medicare AdvantageCoverageMedium impact
MA11.013c, Percutaneous Left Atrial Appendage (LAA) Closure for Non-Valvular Atrial Fibrillation (NVAF)
Independence Blue Cross·Cardiology, Cardiothoracic Surgery·Medical Policy
Effective date
Apr 2, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.013c for Percutaneous Left Atrial Appendage (LAA) Closure procedures for Non-Valvular Atrial Fibrillation has been reissued with updates effective April 2, 2025. This policy change affects coverage criteria and billing requirements for LAA closure procedures under Medicare Advantage plans.
Action Required
By April 2, 2025: Billing team must review the complete updated policy MA11.013c at the provided URL to understand new coverage criteria for LAA closure procedures. Update prior authorization requirements and billing procedures for Medicare Advantage patients requiring percutaneous left atrial appendage closure for non-valvular atrial fibrillation.